Supporting 30 Million Patients on Rare Disease Day
“At the current rate of therapeutic development for rare diseases, it will be 2000 years before doctors won’t have to say to patients, ‘There’s nothing more...
News
The latest news and updates about NYSCF and our collaborators
300 Results
Clear Filters
The Science of Startups: Drs. Derrick Rossi and Paul Tesar Discuss How Their Biotechs Are Bringing Stem Cell Research to Patients
“We had the foundational tools we needed to move our research from academia to biotech,” remarked NYSCF – Robertson Investigator Alumnus Dr. Paul Tesar. “We had...
NYSCF Collaboration Uncovers New Target for Progressive Multiple Sclerosis Therapies
The Context: In multiple sclerosis, the immune system attacks myelin (the fatty substance that surrounds neurons and helps them send signals). Currently, there are no...
What Can Singing Mice Teach Us About Human Conversation?
The Context: The brain activity that enables the rapid back-and-forth of human conversation is likely disrupted in diseases or disorders that interfere with normal communication such...
NYSCF Hosts Panel Discussion on the Future of Alzheimer’s Research and Treatment
44 million people worldwide are affected by Alzheimer’s. 1 in 3 seniors will die with it or a related dementia. The cost of treating Alzheimer’s is...
NYSCF Rings NASDAQ Opening Bell
This morning, NYSCF CEO Susan L. Solomon rang the NASDAQ bell to officially open stock trading for the day. “I’m incredibly optimistic about the future of...
Building New York City’s Life Science Community
This month, NYSCF CEO Susan L. Solomon, JD, spoke at the NYC Builds Bio+ February Quarterly Breakfast (held at the New York Genome Center) about NYSCF’s...
NYSCF Hosts LaunchBio’s “Invest in Cures”
Curing disease takes more than just research– it requires well-planned investment and business strategies that allow science to get done and treatments to move out of...
Using Stem Cells and Gene Editing to Fight Neonatal Diabetes
The Context: Neonatal diabetes affects between 1 and 5 percent of all diabetes patients. It is caused by a single genetic mutation that prevents pancreatic beta...
What’s Next for Regenerative Medicine? NYSCF Drives Discussions at the World Stem Cell Summit
Last week, thousands of researchers and thought leaders gathered at the annual Phacilitate Leaders World and World Stem Cell Summit in Miami to discuss recent advancements...
Growing Tiny Arteries to Fix Big Heart Problems
The Context: When a major heart artery is blocked, the oxygen-starved areas of the heart are kept healthy by smaller arteries called collateral arteries. Some people...
How is Pain Processed in the Brain?
What they did: A team of researchers from Stanford University led by NYSCF – Robertson Neuroscience Investigator and Assistant Professor of Anesthesiology, Neurosurgery, and Perioperative and...
NYSCF Scientists Make Progress Toward Clinical-Grade Bone
What They Did: A team of NYSCF scientists led by NYSCF – Ralph Lauren Senior Principal Investigator Dr. Giuseppe Maria de Peppo tested whether mesenchymal progenitor...
NYSCF Inks Strategic Partnership with Ngene Therapeutics
Research teams will use stem cell and gene editing technologies to advance cell-based therapies for devastating diseases New York, New York (January 9, 2019) – The...
Dr. Ed Boyden Pioneers Method For 3D Printing Nanoscale Objects
What They Did: A team led by NYSCF – Robertson Neuroscience Investigator, MIT Professor of Neurotechnology, and Associate Professor of Biological Engineering and Brain and Cognitive...
Dr. Valentina Fossati Hunts for the Biomarkers Behind MS
What They Did: Researchers at the National Institutes of Health (NIH) and Montana State University along with NYSCF Senior Principal Investigator Dr. Valentina Fossati examined cerebrospinal...
3 NYSCF – Robertson Investigators Receive Award from Chan-Zuckerberg Initiative
It was announced last week that three NYSCF – Robertson Investigators have been named Ben Barres Early Career Investigators by the Chan-Zuckerberg Initiative (CZI). This Early Career...
NYSCF-Supported Research Leads to Successful Phase 2 Clinical Trial for ALS
An epilepsy drug, initially tested using a stem cell model of ALS developed with NYSCF support, has successfully reduced motor neuron excitability (a hallmark of the...
Dr. Sergiu Pasca Receives Award from American College of Neuropsychopharmacology
Congratulations to NYSCF – Robertson Stem Cell Investigator and Assistant Professor of Psychiatry and Behavioral Sciences at Stanford University Sergiu Pasca, MD, for receiving the 2018...
Why We Need Stem Cell Avatars: Susan Solomon Speaks at IGNITION Conference
“It takes 13 years—after you have sunk 4 billion dollars into a drug—to figure out whether or not it will succeed, and your chance of being...
Relieving Depression with Brain Stimulation
What They Did: A team of researchers from the University of California, San Francisco led by NYSCF – Robertson Neuroscience Investigator and Professor of Neurological Surgery...
Claims of First Gene-Edited Babies Spark Concerns
Reports this week that a researcher in China has created genetically modified children using the gene editing technology CRISPR have been met with widespread concern. Dr....
Dr. Valentina Greco Uncovers the Secrets Behind Skin and Hair Regeneration
Our skin is made up of three layers. The top layer – the epidermis – contains epithelial cells, which provide a barrier between us and the...
Dr. Edward Chang Explores the Basis of Mood Disorders
What They Did: A team of researchers from the University of California, San Francisco led by Professor of Neurological Surgery, neurosurgeon, and NYSCF – Robertson Neuroscience...
How Does the Brain Stay Vigilant?
What They Did: A team of researchers from MIT led by NYSCF – Robertson Neuroscience Investigator and Associate Professor in Brain and Cognitive Sciences Kay Tye,...